{
    "nct_id": "NCT05113264",
    "official_title": "A Feasibility Study of Electronic Medication Adherence Reminders and Side Effect Management by an Artificial Intelligence ChatBot Via Mobiles Phones Among Patients With Gastrointestinal Cancers",
    "inclusion_criteria": "* Adults (age >18 years) with a diagnosis of a GI cancer, that is receiving one of the below treatments:\n\n  * Capecitabine ONLY\n  * Capecitabine concurrent with Radiation Therapy\n  * Capecitabine with Temozolomide\n  * Capecitabine with Oxaliplatin\n  * Capecitabine with Mitomycin and concurrent Radiation Therapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "-",
    "miscellaneous_criteria": ""
}